Table 4.
Numbers of the questions from patients regarding DAAs treatment
| Type of questions | Number (%) |
|---|---|
| Adverse drug events | 577 (53.8%) |
| Drug interaction a | 205 (19.1%) |
| Management in the event of a missed dose of DAAs | 57 ( 5.3%) |
| Others | 233 (21.8%) |
| TOTAL | 1,072 (100%) |
DAAs Direct-acting antivirals
a These included questions according to drug-drug (152 cases), drug-supplement (32 cases), and drug-food (21 cases) interactions